Analytical methods for the separation and quantification of enantiomers of bupropion and 4-hydroxybupropion are very limited. Information on the stereoselective disposition of threo- and erythro-dihydrobupropion is nonexistent.
A novel, accurate and precise stereoselective HPLC–MS/MS method was developed to quantify bupropion and its metabolites in human plasma samples.
This method was successfully implemented to determine the unique stereoselective pharmacokinetics of bupropion and its metabolites in human.
This new quantification method should enhance further research into bupropion stereoselective metabolism.